Literature DB >> 20171801

Predictive factors of late radiation fibrosis: a prospective study in non-small cell lung cancer.

Renaud Mazeron1, Bénédicte Etienne-Mastroianni, David Pérol, Dominique Arpin, Michel Vincent, Lionel Falchero, Isabelle Martel-Lafay, Christian Carrie, Line Claude.   

Abstract

PURPOSE: To determine predictive factors of late radiation fibrosis (RF) after conformal radiotherapy (3D-RT) in non-small cell lung cancer (NSCLC). METHODS AND MATERIALS: Ninety-six patients with Stage IA-IIIB NSCLC were included in a prospective trial. Clinical evaluation, chest X-ray, and pulmonary functional tests including diffusion parameters were performed before and 6 months after radiotherapy. An independent panel of experts prospectively analyzed RF, using Late Effects in Normal Tissues-Subjective, Objective, Management and Analytic scales classification. Logistic regression analysis was performed to identify relationships between clinical, functional, or treatment parameters and incidence of RF. Variations of circulating serum levels of pro-inflammatory (interleukin-6, tumor necrosis factor alpha, tumor growth factor beta1) and anti-inflammatory (interleukin-10) cytokines during 3D-RT were examined to identify correlations with RF.
RESULTS: Of the 96 patients included, 72 were evaluable for RF at 6 months. Thirty-seven (51.4%) developed RF (Grade >or=1), including six severe RF (Grades 2-3; 8.3%). In univariate analysis, only poor Karnofsky Performance Status and previous acute radiation pneumonitis were associated with RF (p < 0.05). Dosimetric factors (mean lung dose, percentage of lung volume receiving more than 10, 20, 30, 40, and 50 Gy) were highly correlated with RF (p < 0.001). In multivariate analysis, previous acute radiation pneumonitis and dosimetric parameters were significantly correlated with RF occurrence. It was not significantly correlated either with cytokines at baseline or with their variation during 3D-RT.
CONCLUSIONS: This study confirms the importance of dosimetric parameters to limit the risk of RF. Contrary to acute radiation pneumonitis, RF was not correlated to cytokine variations during 3D-RT.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20171801     DOI: 10.1016/j.ijrobp.2009.04.019

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  19 in total

1.  Amelioration of radiation-induced pulmonary fibrosis by a water-soluble bifunctional sulfoxide radiation mitigator (MMS350).

Authors:  Ronny Kalash; Michael W Epperly; Julie Goff; Tracy Dixon; Melissa M Sprachman; Xichen Zhang; Donna Shields; Shaonan Cao; Darcy Franicola; Peter Wipf; Hebist Berhane; Hong Wang; Jeremiah Au; Joel S Greenberger
Journal:  Radiat Res       Date:  2013-10-14       Impact factor: 2.841

2.  NRF2 deficiency reduces life span of mice administered thoracic irradiation.

Authors:  Elizabeth L Travis; Girish Rachakonda; Xinhui Zhou; Katrina Korhonen; Konjeti R Sekhar; Swati Biswas; Michael L Freeman
Journal:  Free Radic Biol Med       Date:  2011-06-12       Impact factor: 7.376

3.  Differences in irradiated lung gene transcription between fibrosis-prone C57BL/6NHsd and fibrosis-resistant C3H/HeNHsd mice.

Authors:  Ronny Kalash; Hebist Berhane; Jeremiah Au; Byung Han Rhieu; Michael W Epperly; Julie Goff; Tracy Dixon; Hong Wang; Xichen Zhang; Darcy Franicola; Ashwin Shinde; Joel S Greenberger
Journal:  In Vivo       Date:  2014 Mar-Apr       Impact factor: 2.155

4.  Immediate Release of Gastrin-Releasing Peptide Mediates Delayed Radiation-Induced Pulmonary Fibrosis.

Authors:  Robert M Tighe; Karissa Heck; Erik Soderblom; Shutang Zhou; Anastasiya Birukova; Kenneth Young; Douglas Rouse; Jessica Vidas; Miglena K Komforti; Christopher B Toomey; Frank Cuttitta; Mary E Sunday
Journal:  Am J Pathol       Date:  2019-03-18       Impact factor: 4.307

Review 5.  Molecular mechanisms and treatment of radiation-induced lung fibrosis.

Authors:  Nian-Hua Ding; Jian Jian Li; Lun-Quan Sun
Journal:  Curr Drug Targets       Date:  2013-10       Impact factor: 3.465

6.  Correlations Between Serum IL-6 Levels and Radiation Pneumonitis in Lung Cancer Patients: A Meta-Analysis.

Authors:  Zhan-Zhao Fu; Yong Peng; Li-Yan Cao; Yan-Sheng Chen; Kun Li; Bao-Hong Fu
Journal:  J Clin Lab Anal       Date:  2014-12-26       Impact factor: 2.352

7.  Lipopolysaccharide-binding protein is efficient in biodosimetry during radiotherapy of lung cancer.

Authors:  Justyna Chalubinska-Fendler; Wojciech Fendler; Michal Spych; Krystyna Wyka; Jolanta Luniewska-Bury; Jacek Fijuth
Journal:  Biomed Rep       Date:  2016-08-08

8.  Effects of thoracic irradiation on pulmonary endothelial compared to alveolar type-II cells in fibrosis-prone C57BL/6NTac mice.

Authors:  Ronny Kalash; Hebist Berhane; Julie Goff; Frank Houghton; Michael W Epperly; Tracy Dixon; Xichen Zhang; Melissa M Sprachman; Peter Wipf; Darcy Franicola; Hong Wang; Joel S Greenberger
Journal:  In Vivo       Date:  2013 May-Jun       Impact factor: 2.155

9.  Changes in Regional Ventilation During Treatment and Dosimetric Advantages of CT Ventilation Image Guided Radiation Therapy for Locally Advanced Lung Cancer.

Authors:  Tokihiro Yamamoto; Sven Kabus; Matthieu Bal; Karl Bzdusek; Paul J Keall; Cari Wright; Stanley H Benedict; Megan E Daly
Journal:  Int J Radiat Oncol Biol Phys       Date:  2018-05-04       Impact factor: 7.038

10.  A prospective study of the feasibility of FDG-PET/CT imaging to quantify radiation-induced lung inflammation in locally advanced non-small cell lung cancer patients receiving proton or photon radiotherapy.

Authors:  Pegah Jahangiri; Kamyar Pournazari; Drew A Torigian; Thomas J Werner; Samuel Swisher-McClure; Charles B Simone; Abass Alavi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-09-18       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.